NCT00479258|TerminatedPhase 3Results
Study Stopped
See termination reason in detailed description.
Loading search results
See termination reason in detailed description.
Sponsor study identifier
interventional
2
1 country
1
Study Start
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2007
Actual (reported)Study Completion
October 2007
Actual (reported)To assess the safety and efficacy of Exubera on pulmonary function and glycemic control in subjects ages 6-17 over a 1 year period.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 24, 2007
Actual (reported)May 28, 2007
Actual (reported)October 2007
Date type not reportedThis date has not been verified as actual or estimated.
October 2007
Actual (reported)October 2007
Actual (reported)November 3, 2008
Actual (reported)To Assess Pulmonary Safety and Glycemic Control of Exubera Over a 12 Month Controlled Period
No subjects were dosed therefore no data collected.
12 months
Change From Baseline in Other PFT Parameters
12 months
Slope From Baseline to Week 52 and Slope From Week 12 to Week 52 for FEV1 and FVC as a Percent of Predicted;
12 months
Treatment Preferences.
12 months
Change From Baseline in FVC
12 months
Slope for Other PFT Parameters;
12 months
Inhaled insulin with dose adjusted according to premeal blood glucose
Subcutaneous insulin with dose adjusted according to premeal blood glucose
Pfizer Investigational Site
Buffalo, New York, 14222, United States
Pfizer announced Oct07 it would stop marketing Exubera; recruitment placed on hold. Nektar, from which Pfizer licensed Exubera, announced April 9, 2008 it had stopped its search for a new marketing partner. Study terminated; no further recruitment.
Pfizer CT.gov Call Center
Pfizer
2 participants (actual enrollment reported by the registry).
First Submitted
May 24, 2007
First Posted
May 28, 2007
Study Start
October 2007
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
October 2007
Actual (reported)Study Completion
October 2007
Actual (reported)Last Updated
October 1, 2018
Results First Posted
November 3, 2008
Record last verified: 2018-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: